Sava Infond d.o.o.

Position in ABT — Abbott Laboratories

CIK 2055882 MARIBOR, 2A

Position in ABT

as of Jun 30, 2026 · filed Jul 16, 2026 Compact

Position Value

$2,136,927

-$895,944 QoQ

Shares Held

23,550

-20.3% QoQ

Ownership

0.001%

of shares outstanding

% of Portfolio

0.16%

of 13F equity value

Holder Rank

#1,060

of 2,959 holders

Holding Since

Dec 2024

7 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Sava Infond d.o.o. holds $8,011,225 across 6 Medical Devices names. ABT ranks #2 (26.7% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	BSX	Boston Scientific Corp	87,020	$3,714,012
2	ABT	Abbott Laboratories This page	23,550	$2,136,927
3	SYK	Stryker Corp	2,150	$676,906
4	MDT	Medtronic plc	8,350	$653,220
5	DXCM	Dexcom Inc	7,155	$481,889
6	EW	Edwards Lifesciences Corp	3,850	$348,271

7 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$2,136,927	23,550	-20.3%	Shares	Defined	2026-07-16
2026-03-31	$3,032,871	29,540	-2.4%	Shares	Defined	2026-05-11
2025-12-31	$3,793,781	30,280	-9.6%	Shares	Defined	2026-01-29
2025-09-30	$4,486,990	33,500	-2.0%	Shares	Sole	2025-11-10
2025-06-30	$4,651,542	34,200	-0.7%	Shares	Sole	2025-07-22
2025-03-31	$4,568,466	34,440	+1.8%	Shares	Sole	2025-04-23
2024-12-31	$3,826,511	33,830	—	Shares	Sole	2025-02-12
No filing history on record for this holder in this stock.